[The pharmacology of 1-propyl-3-methyl-7-(5-hydroxyhexyl) xanthine (HWA 153), a new bronchodilatory xanthine derivative].
D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D010276:Parasympatholytics; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
D001993:Bronchodilator Agents; D010276:Parasympatholytics; D013806:Theophylline
Zur Pharmakologie des 1-Propyl-3-methyl-7-(5-hydroxyhexyl)-xanthin (HWA 153), eines neuen bronchospasmolytisch wirksamen Xanthin-Derivates.